期刊文献+

阿司匹林抵抗研究进展 被引量:4

暂未订购
导出
摘要 阿司匹林被临床广泛用于预防和治疗血栓栓塞性疾病。阿司匹林抵抗(AR)现象受到广泛关注,目前关于AR的研究越来越多。该文综述AR的临床检测方法、发生机制及防治策略等问题。
出处 《医药导报》 CAS 北大核心 2013年第8期981-984,共4页 Herald of Medicine
基金 湖北省卫生厅科研项目资助(No.JX5B01)
  • 相关文献

参考文献33

  • 1KUZNIATSOVA N, SHANTSILA E, BLANN A, et al. A contemporary viewpoint on "aspirin resistance" [ J ]. Ann Med ,2012,44 ( 8 ) : 773-783.
  • 2CA33"ANEO M. Aspirin and clopidogrel:efficacy, safety, and the issue of drug resistance [ J ]. Arterioscler Thromb Vasc Biol, 2004,24( 11 ) : 1980-1987.
  • 3BEN-DOR I, KLEIMAN NS, LEV E. Assessment, mech- anisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy [ J ]. Am J Cardiol, 2009,104(2) :227-233.
  • 4GURBEL P A, BLIDEN K P, HIATF B L, et al. Clopi- dogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity [ J ]. Circulation, 2003,107 ( 23 ) :2908-2913.
  • 5SOREL N, BRABANT S, CHRISTIAENS L, et al. A rapid and specific whole blood HPA-1 phenotyping by flow cytometry using two commercialized monoclonal antibodies directed against GP Ilia and GP Ilb-llIa complexes[ J]. Br J Haematol, 2004,124 ( 2 ) : 221-223.
  • 6MICHELSON A D, BARNARD M R, KRUEGER L A, et al. Evaluation of platelet function by flow cytometry [ J ]. Methods, 2000,21 (3) :259-270.
  • 7QAYYUM R, BECKER D M, YAENK L R, et al. Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease [J]. Am J Cardiol, 2008,101(9) :1359-1363.
  • 8GURBEL P A, BECKER R C, MANN K G, et al. Platelet function monitoring in patients with coronary artery disease [ J ]. J Am Coil Cardio1,2007,50 ( 19 ) : 1822-1834.
  • 9GRAEME J HANKEY, JOHN W EIKELBOOM. Aspirin resistance. Lancet, 2006,367 (10) :606-617.
  • 10MICKELSON A D. Platelet function testing in cardiovas- cular diseases [ J ]. Circulation, 2004, 110 ( 19 ) : 489 - 493.

同被引文献43

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部